This systematic review and meta-analysis aimed to comprehensively evaluate the factors
associated with mortality and progressive disease in NTM-LD patients. We conducted a …

Rationale: Because the prognosis of nontuberculous mycobacterial pulmonary disease
varies, a scoring system predicting mortality is needed. Objectives: We aimed to develop a …

A uniform prognostic marker is needed for nontuberculous mycobacterial pulmonary
disease (NTM-PD) due to the diverse clinical course. We aimed to seek the utility of the …

Abstract Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) is a chronic disease
characterised by progressive inflammatory lung damage due to infection by non-tuberculous …

Objectives Limited data are available on the progression of pulmonary Mycobacterium
avium complex (MAC) disease without culture-positive sputum. The aim of this study was to …

Background Nontuberculous mycobacterial pulmonary disease (NTM-PD), a chronic
respiratory condition, presents a growing challenge globally. Uncertainties exist regarding …

BACKGROUND: The severity of non-tuberculous mycobacterial pulmonary disease (NTM-
PD) can be classified based on an assessment of the patient´ s body mass index, age …

Background: It remains unclear whether erythrocyte sedimentation rate (ESR) accurately
predicts prognosis during treatment and how ESR changes. Objectives: We aimed to assess …

Objectives A single isolate of nontuberculous mycobacterium (NTM) from bronchoscopic
samples satisfies the microbiological criterion for diagnosing NTM-pulmonary disease (PD) …

SETTING: Diagnosis of Mycobacterium avium complex pulmonary disease (MAC-PD)
requires positive culture of expectorated sputum or specimens acquired by bronchoscopy …